Assyro AI

Orange Book product · Generic (ANDA)

ORPHENGESIC

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Generic (ANDA)ANDA 075141RX GALT PHARMS

At a glance

May 29, 1998

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 29, 1998

    28 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Strength

385MG;30MG;25MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 075141

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.